172526-43-1 Usage
Description
(5S,1'S)-3-phenylmethyl-5-(1'-N,N-dibenzylamino-2'-phenylethyl)-2-isoxazoline is a complex chemical compound characterized by its chiral center, a phenylmethyl group, a dibenzylamino-phenylethyl group, and an isoxazoline ring. (5S,1'S)-3-phenylmethyl-5-(1'-N,N-dibenzylamino-2'-phenylethyl)-2-isoxazoline's stereochemistry is indicated by its (5S,1'S) designation, and the presence of the dibenzylamino-phenylethyl group suggests potential pharmacological activity in the central nervous system. The isoxazoline ring, a five-membered heterocycle with nitrogen and oxygen atoms, contributes unique chemical reactivity and biological properties to the molecule, making it a compound of potential interest in the field of pharmacology.
Uses
There are no specific uses provided in the materials for (5S,1'S)-3-phenylmethyl-5-(1'-N,N-dibenzylamino-2'-phenylethyl)-2-isoxazoline. However, given its structural features and potential pharmacological activity, it may be used in various applications within the pharmaceutical and chemical industries. Further research and development would be required to determine its specific uses and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 172526-43-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,2,5,2 and 6 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 172526-43:
(8*1)+(7*7)+(6*2)+(5*5)+(4*2)+(3*6)+(2*4)+(1*3)=131
131 % 10 = 1
So 172526-43-1 is a valid CAS Registry Number.
172526-43-1Relevant articles and documents
2-isoxazoline derivative and process for producing the same, and process for producing related derivatives from the same
-
, (2008/06/13)
The present invention provides useful intermediates for the synthesis of 2,5-diamino-1,6-diphenyl-3-hydroxyhexane derivatives which serve as intermediates in the synthesis of medicines such as retrovirus protease inhibitors including human immunodeficiency virus (HIV) protease inhibitors, and a method for preparing these intermediates using the former intermediates. More particularly, the invention provides methods for preparing a 2-isoxazoline derivative represented by formula ?1! and a 2,5-diamino-1,6-diphenyl-3-hydroxyhexane derivative obtainable by reducing the 2-isoxazoline derivative and represented by formula ?6!: STR1 (wherein Ph is phenyl; and each of R1 and R2 independently represents hydrogen, acyl, alkyloxycarbonyl, arylalkyloxycarbonyl, aryloxycarbonyl, alkylaminocarbonyl, arylalkylaminocarbonyl, arylaminocarbonyl, alkyl, arylalkyl, aryl, alkylsulfonyl, arylalkylsulfonyl, or arylsulfonyl, or R1 and R2 are linked to each other to represent divalent acyl).
